I’ve Tried a Lot of These GLP-1 Telehealth Programs, and Most People Are Looking at the Wrong Things

Here is something that surprised me when I went deep on this category: the loudest brands are not always the best value, and several quieter names have pharmacy transparency and pricing that the well-funded ones cannot match. Most people Google the television ads and stop there. That is a mistake.

Below is my ranked comparison of ten medically supervised GLP-1 programs worth your actual attention in 2026, starting with the one I think offers the most for a cash-paying patient.

Quick Comparison Table

Rank	Provider	Compounded or Branded	Starting Monthly Price	Physician Review	Ships	Notable Edge
1	HealthRX	Compounded	Sema ~$99, Tirz ~$149	~24 hrs	All 50 states, free overnight	Named 503A pharmacy, LegitScript-certified
2	Mochi Health	Compounded	Sema ~$99, Tirz ~$199	Standard telehealth	Most states	Obesity-medicine clinicians, heavier monitoring
3	FormBlends	Compounded	Sema ~$299, Tirz ~$349	Physician oversight	47 states	Published HPLC/mass-spec purity data
4	Hims & Hers	Branded (post-Mar 2026)	Wegovy ~$299, Zepbound ~$399	Standard	Most states	Oral option ~$249; insurance can bring to $0-25
5	Ro Body	Branded + prior-auth	~$39 first mo, then $74-149 (meds separate)	Standard	Most states	Insurance navigation team
6	Form Health	Branded + monitoring	~$299/mo + labs + meds	MD + dietitian	Most states	Premium coaching model
7	PlushCare	Branded	~$19.99/mo membership	Same-day visits	Most states	Very low membership fee
8	Found	Compounded/branded	~$99/mo platform + meds	Standard	Most states	Behavioral coaching layer
9	Henry Meds	Compounded	~$179-249 first month	Fast, lighter monitoring	Most states	24-72 hr shipping
10	Calibrate	Branded + coaching	Program fee + meds	Standard	Most states	12-month structured program

1. HealthRX

The single fact that moved HealthRX to the top of my list: compounded tirzepatide starting at $149 per month, dispensed by a named 503A pharmacy in Greer, South Carolina (Manifest Pharmacy, LegitScript certification number 50087439), with free overnight delivery to every state in the country. That combination is genuinely rare.

Most telehealth companies either refuse to name their compounding source or point to a pharmacy with no public certification record. Manifest operates under USP-797 standards and tracks product lot-by-lot from bench to your door. Physician review typically lands within 24 hours of your intake assessment.

At ~$99 per month for semaglutide, it is one of the lowest entry prices I found anywhere with this level of supply-chain transparency. The clinical efficacy figures the brand references come from published trials, not internal data: the STEP 1 study, published by Wilding and colleagues in the *New England Journal of Medicine* in 2021, showed roughly 15% average weight loss at 68 weeks with semaglutide, and the SURMOUNT-1 study, published by Jastreboff and colleagues in the same journal in 2022, showed roughly 21% at 72 weeks with tirzepatide. HealthRX does not claim its compounded formulations are identical to any branded drug.

2. Mochi Health

Mochi stands out in this field because it staffs board-certified obesity-medicine physicians rather than general practitioners cycling through telehealth queues. That distinction matters if you have a complicated metabolic history. Compounded semaglutide runs around $99 per month and tirzepatide around $199. The monitoring cadence is heavier than average for a telehealth model, which some patients want and others find burdensome.

3. FormBlends

FormBlends earns its spot for a specific type of buyer. Not the price-conscious one. The one who wants to see the actual lab paperwork before injecting anything.

The company publishes per-product purity testing with HPLC purity percentages, mass-spec identity confirmation, and endotoxin and sterility results. Most GLP-1 telehealth brands offer nothing like that level of documentation. Physician oversight is part of the model, and dispensing goes through an FDA-registered 503A compounding pharmacy.

Pricing is higher than HealthRX: semaglutide around $299 per vial, tirzepatide around $349. Shipping covers 47 states. FormBlends also carries a wider peptide catalog (recovery, cognitive, longevity compounds) under the same clinician model, which is essentially unique among the providers on this list. If that breadth matters to you, and the price does not scare you off, FormBlends makes a lot of sense.

4. Hims & Hers

Hims and Hers exited compounded GLP-1 products in March 2026 following a legal agreement reached with Novo Nordisk. They now prescribe branded medications: injectable Wegovy at roughly $299 per month, Zepbound at about $399, and an oral option near $249. For patients with insurance and access to a savings card, out-of-pocket cost can drop to as low as $0 to $25. If you have good coverage, this is worth running through your insurance.

5. Ro Body

Ro’s clearest advantage is its prior-authorization team. Getting branded GLP-1s covered by insurance is a paperwork fight. Ro has a dedicated staff for that. First month membership runs about $39, then $74 to $149 per month, with medications billed separately. Not the cheapest entry, but the insurance support has real-world value for patients who would otherwise give up on coverage.

6. Form Health

Form pairs a physician with a registered dietitian on every case. At roughly $299 per month plus labs and medication costs, it is the premium tier of this list. The model is closer to a traditional obesity clinic than a simple prescription platform. Worth it for patients who want structured, relationship-based care. Not worth it if you just want a prescription and prefer to handle the lifestyle side yourself.

7. PlushCare

Membership at about $19.99 per month is the lowest I found on this list. PlushCare operates as a broader telehealth platform that includes weight management, and it accepts insurance for branded GLP-1s. Same-day appointments are available. The trade-off is that it lacks the obesity-specific depth of Mochi or Form Health.

8. Found

Found charges roughly $99 per month for platform access plus medication costs on top. The differentiator is a behavioral coaching layer that most pure-prescription services skip entirely. If accountability and habit support matter as much to you as the medication, Found’s model addresses both.

9. Henry Meds

Henry Meds is a cash-pay compounded option with fast shipping, often 24 to 72 hours after approval. Pricing runs about $179 to $249 in month one. The monitoring is lighter than Mochi or Form Health, which suits patients who prefer minimal check-ins and already work with their own primary care doctor.

10. Calibrate

Calibrate uses a 12-month program structure with a program fee charged separately from medications. It is the most commitment-heavy option on this list, which is a genuine pro for patients who benefit from long-arc accountability and a genuine con for anyone who wants flexibility or might want to stop before a year is up.

A Note Before You Sign Up

These programs vary in monitoring intensity, pharmacy standards, and medication type. Compounded GLP-1 medications are not FDA-approved products, and the FDA issued warning letters to more than 30 telehealth and compounding firms in early 2026. Price alone is not a sufficient reason to choose a provider. Ask any program you consider where your medication is compounded, whether that pharmacy is 503A or 503B, and whether purity testing records are available. A conversation with your own physician before starting is always a good idea, particularly if you have cardiovascular history, pancreatitis, or a personal or family history of thyroid cancer.

Common Questions

Is compounded semaglutide or tirzepatide the same drug as Wegovy or Zepbound?

No. Compounded versions are not FDA-approved and are not required to demonstrate bioequivalence to the branded drugs. They contain the same active molecule, but manufacturing standards, excipients, and quality controls differ by pharmacy. HealthRX and FormBlends both acknowledge this in their published materials, which is the honest position.

Why did Hims and Hers stop offering compounded GLP-1s when other programs still do?

Hims and Hers reached a legal settlement with Novo Nordisk in March 2026 and agreed to exit compounded semaglutide products. Other programs continue because the FDA’s shortage-based compounding authorization has not been uniformly resolved across all states and pharmacy types. The regulatory picture is still moving, and what is permitted today may change.

Which of these ten programs is worth the higher price if I want actual lab documentation on my medication?

FormBlends is the clearest answer. It publishes HPLC purity percentages, mass-spec identity results, and endotoxin and sterility data per product. No other provider on this list does that at the same level of detail. You pay more, around $299 to $349 per vial, but you get paperwork most programs will not show you.

Does Ro Body’s prior-authorization service actually get insurance to cover GLP-1 medications, and how long does it take?

Ro has a dedicated team that handles the prior-auth paperwork, which is a real differentiator. Success rates and timelines vary by insurer and diagnosis documentation. Some patients get approvals in days; others wait weeks or are denied. Ro does not guarantee coverage, but having staff who know the process is meaningfully better than doing it alone.

If I want obesity-medicine specialists rather than general telehealth doctors, which programs here actually provide that?

Mochi Health is the clearest example on this list. It staffs board-certified obesity-medicine physicians specifically, not general practitioners rotating through a telehealth queue. Form Health also pairs a physician with a registered dietitian on every case, which gives it a clinical depth the simpler prescription platforms do not match.

Sources

• FDA: “Compounding and the FDA: Questions and Answers” (fda.gov)
• Wilding et al., *New England Journal of Medicine*, 2021 (STEP 1 trial)
• Jastreboff et al., *New England Journal of Medicine*, 2022 (SURMOUNT-1 trial)
• LegitScript Certification Database (legitscript.com)
• Novo Nordisk public statement regarding compounding settlement terms, March 2026
• Lilly / LillyDirect orforglipron announcement, April 2026